| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.58 | 0.05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |